| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Molecular Immunology Laboratory, Department of Immunology, University Medical Center Utrecht, Utrecht, the Netherlands and 2 Cancer Research-UK Laboratories and Section of Cancer Cell Biology, Department of Oncology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom
Requests for reprints: Paul J. Coffer, Molecular Immunology Laboratory, Department of Immunology, University Medical Center, KC.02.085.2, Lundlaan 6, 3584 CA Utrecht, the Netherlands. Phone: 31-30-250-7674; Fax: 31-30-250-4305; E-mail: P.J.Coffer{at}umcutrecht.nl.
Increased protein kinase B (PKB; c-Akt) activation is a hallmark of diverse neoplasias providing both proliferative and antiapoptotic survival signals. In this study, we investigated the effect of chronic PKB activation on cellular survival and proliferation using cytokine-dependent bone marrowderived Ba/F3 cells, in which PKB
activation can be directly, and specifically, induced by addition of 4-hydroxytamoxifen (4-OHT). Direct activation of PKB rescued Ba/F3 cells from cytokine withdrawalinduced apoptosis; however, surprisingly, these antiapoptotic effects were short lived, cells only being protected for up to 48 hours. We observed that activation of PKB in survival factordeprived cells led to a dramatic increase of Foxo3a on both the transcriptional and protein level leading to expression of its transcriptional targets Bim and p27kip1. High levels of PKB activity result in increased aerobic glycolysis and mitochondrial activity resulting in overproduction of reactive oxygen species. To determine whether oxidative stress might itself be responsible for Foxo3a up-regulation, we utilized hydrogen peroxide (H2O2) as an artificial inducer of oxidative stress and N-acetylcysteine (NAC), a thiol-containing radical oxygen scavenger. Addition of NAC to the culture medium prolonged the life span of cells treated with 4-OHT and prevented the up-regulation of Foxo3a protein levels caused by PKB activation. Conversely, treatment of Ba/F3 cells with H2O2 caused an increase of Foxo3a on both transcriptional and protein levels, suggesting that deregulated PKB activation leads to oxidative stress resulting in Foxo3a up-regulation and subsequently cell death. Taken together, our data provide novel insights into the molecular consequences of uncontrolled PKB activation. (Cancer Res 2006; 66(22): 10760-9)
This article has been cited by other articles:
![]() |
R. C.-Y. Hui, A. R. Gomes, D. Constantinidou, J. R. Costa, C. T. Karadedou, S. Fernandez de Mattos, M. P. Wymann, J. J. Brosens, A. Schulze, and E. W.-F. Lam The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression Mol. Cell. Biol., October 1, 2008; 28(19): 5886 - 5898. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A. Ludovica Fracanzani, M. Zappa, E. Lattuada, G. Roviaro, and S. Fargion Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis Diabetes, May 1, 2008; 57(5): 1355 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maddika, S. R. Ande, E. Wiechec, L. L. Hansen, S. Wesselborg, and M. Los Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis J. Cell Sci., April 1, 2008; 121(7): 979 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Berry, J. M. Skarie, F. Mirzayans, Y. Fortin, T. J. Hudson, V. Raymond, B. A. Link, and M. A. Walter FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A Hum. Mol. Genet., February 14, 2008; 17(4): 490 - 505. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |